-+ 0.00%
-+ 0.00%
-+ 0.00%

Inozyme Pharma Q1 EPS $(0.44) Misses $(0.41) Estimate

Benzinga·05/14/2025 11:35:14
Listen to the news
Inozyme Pharma (NASDAQ:INZY) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.41) by 7.32 percent. This is a 15.79 percent decrease over losses of $(0.38) per share from the same period last year.